Related Experiment Video

Updated: Aug 25, 2026

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
09:25

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum

Published on: September 18, 2018

Management of severe falciparum malaria

P Njuguna1, C Newton

  • 1Centre for Geographic Medicine Research-Coast, Kenya Medical Research Institute, Kilifi, Kenya.

Journal of Postgraduate Medicine
|March 30, 2004
PubMed

Insights

Severe malaria, primarily caused by Plasmodium falciparum, is a major global health threat, especially for African children. Prompt treatment and intensive care are crucial for reducing mortality and long-term neuro-cognitive sequelae.

Area of Science:

  • Malariology
  • Infectious Diseases
  • Global Health

Background:

  • Plasmodium falciparum causes severe, life-threatening malaria, leading to over a million deaths annually, predominantly in African children under five.
  • Severe malaria presentation and outcomes differ significantly between age groups and geographic regions, with higher mortality in adults but more frequent neuro-cognitive sequelae in African children.
  • Effective management involves prompt parenteral antimalarial treatment and early recognition/management of complications.

Purpose of the Study:

  • To outline the varied clinical presentations and complications of severe malaria across different age groups and geographical locations.
  • To emphasize the critical role of timely interventions, including parenteral antimalarials and intensive care, in managing severe malaria.
  • To highlight age-specific complications, such as metabolic acidosis and seizures in children, and renal failure and pulmonary edema in adults.

Main Methods:

  • Review of clinical presentations and outcomes of severe malaria.
  • Analysis of age- and geographically-specific complications and mortality factors.
  • Emphasis on management strategies including parenteral antimalarials and critical care.

Main Results:

  • Severe malaria exhibits distinct patterns in children and adults, with African children experiencing more frequent neuro-cognitive sequelae.
  • Key complications in children include metabolic acidosis, hypoglycemia, severe anemia, seizures, and bacterial infections.
  • Adults are more prone to renal failure and pulmonary edema, which are common causes of death.

Conclusions:

  • Prompt and appropriate management, including parenteral antimalarials and intensive care, is essential for reducing mortality and sequelae in severe malaria.
  • Recognizing age-specific complications and comorbidities, such as bacterial infections in children, is vital for effective treatment.
  • Admission to critical or intensive care units can significantly improve outcomes and reduce the severity of long-term effects.

More Related Videos

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...